BeyondAirInc . (NASDAQ:XAIR) Downgraded to Hold at ValuEngine

BeyondAirInc . (NASDAQ:XAIR) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday, ValuEngine reports.

Separately, Zacks Investment Research lowered BeyondAirInc . from a “hold” rating to a “sell” rating in a research note on Saturday.

Shares of XAIR stock traded down $0.14 during trading hours on Monday, hitting $4.36. The company had a trading volume of 1,673 shares, compared to its average volume of 19,947. BeyondAirInc . has a 12 month low of $3.11 and a 12 month high of $6.25. The company has a market cap of $48.35 million, a price-to-earnings ratio of -5.19 and a beta of -0.27. The stock’s fifty day moving average is $4.68.

BeyondAirInc . (NASDAQ:XAIR) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.20). The firm had revenue of $0.63 million during the quarter, compared to the consensus estimate of $1.25 million. On average, equities research analysts anticipate that BeyondAirInc . will post -1.14 earnings per share for the current year.

BeyondAirInc . Company Profile

Beyond Air, Inc, a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria.

See Also: What is a good dividend yield?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit